Multicenter examination showed biomarkers in cerebrospinal fluid consistently distinguished MS from other ...
A new AI foundation model from Mass General Brigham may be capable of analyzing brain MRI datasets and predict various ...
Khaberni - Out of every 125 million people, only one contracts the disease known as 'CIPA' (Congenital Insensitivity to Pain with Anhidrosis), and in broader estimates for the general lack of pain ...
Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...
Boris Mizhen is proud to sponsor such a historic and famous institution and is excited to witness what further developments it will achieve in its future. Yale-New Haven Hospital boasts an impressive ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI ® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...
BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...
Trump launched TrumpRx, a new website offering discounted prescription medicines. See how to use it, which drugs are included ...
Stroke patients face unequal access to clot-removal care; race and insurance shape transfers, even with Medicare—here’s what must change, according to Luke Messac, MD, PhD. Disparities in access to ...
GSK announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults in the EU with uncontrolled COPD characterised by raised blood eosinophils ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results